United States Patent 11,197,847: A Detailed Analysis of Scope, Claims, and Patent Landscape
Introduction
United States Patent 11,197,847, titled "Isoxazoline parasiticide formulations and methods for treating parasites," is a significant patent in the field of veterinary medicine and parasitology. This patent, granted on December 14, 2021, protects formulations and methods related to isoxazoline parasiticides. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.
Patent Overview
Title and Abstract
The patent titled "Isoxazoline parasiticide formulations and methods for treating parasites" focuses on novel formulations and treatment methods using isoxazoline compounds. These compounds are known for their efficacy against various parasites in animals, particularly ticks, fleas, and other ectoparasites.
Background
Isoxazoline compounds have gained prominence in recent years due to their potent parasiticidal activity and safety profile. This patent builds upon existing research and development in the field, offering improved formulations and treatment regimens.
Scope of the Patent
Claims
The patent includes multiple claims that define the scope of the invention. Here are some key aspects:
- Claim 1: This claim describes the composition of the isoxazoline parasiticide formulation, including the active ingredients, excipients, and the method of administration.
- Claim 2-5: These claims specify different embodiments of the formulation, such as varying concentrations of the active ingredients and different forms of administration (e.g., topical, oral).
- Claim 6-10: These claims cover the methods of treating parasites using the isoxazoline formulations, including the dosage regimens and the types of parasites targeted[5].
Dependencies and Continuations
The patent is a continuation application of U.S. patent application Ser. No. 17/099,531, filed on October 28, 2020. This indicates that the current patent builds upon previous work and may incorporate new developments or improvements over the earlier application[5].
Patent Family and International Coverage
Patent Family
The patent has sixteen patent family members in thirteen countries, indicating a broad international protection strategy. This is crucial for ensuring global market exclusivity and preventing unauthorized use of the invention in various jurisdictions[2].
International Patent Offices
The protection of this patent is not limited to the United States. It is part of a larger global patent strategy, with filings in multiple countries. This is facilitated by international patent databases and services such as the European Patent Office's esp@cenet, the Japan Patent Office, and the World Intellectual Property Organization's PATENTSCOPE[1].
Patent Landscape
Related Patents and Prior Art
To understand the patent landscape, it is essential to identify related patents and prior art. Tools like the Common Citation Document (CCD) and the Patent Public Search tool provided by the USPTO can help in this regard. The CCD consolidates prior art cited by all participating IP5 Offices, providing a comprehensive view of the prior art landscape for the same invention[1].
Competitors and Market Impact
The isoxazoline market is competitive, with several other companies and researchers working on similar compounds. The grant of this patent provides the holder with a competitive edge, allowing them to market and sell their formulations exclusively. This can significantly impact the market, particularly in the veterinary pharmaceutical sector.
Economic and Legal Implications
Allowance Rates and Examination Process
The probability of receiving a patent, especially in the chemical and pharmaceutical fields, can be complex due to the rigorous examination process. The USPTO's internal databases and the Patent Application Information Retrieval (PAIR) system provide insights into the examination outcomes and continuation procedures, which are crucial for understanding the patent's validity and scope[4].
Small vs. Large Entities
Research indicates that patent applications filed by small entities are less likely to be granted compared to those filed by large entities. This patent, being part of a larger family with international coverage, suggests that it is likely filed by a larger entity with significant resources[4].
Key Takeaways
- Patent Scope: The patent covers specific isoxazoline parasiticide formulations and treatment methods.
- Claims: Multiple claims define the composition, method of administration, and treatment regimens.
- International Coverage: The patent has a broad international protection strategy with filings in thirteen countries.
- Market Impact: The patent provides a competitive edge in the veterinary pharmaceutical market.
- Economic Implications: The patent's grant and scope can influence market dynamics and competition.
FAQs
What is the main subject of United States Patent 11,197,847?
The main subject of United States Patent 11,197,847 is isoxazoline parasiticide formulations and methods for treating parasites.
How does this patent relate to other patent applications?
This patent is a continuation application of U.S. patent application Ser. No. 17/099,531, indicating it builds upon previous work.
What is the international coverage of this patent?
The patent has sixteen family members in thirteen countries, providing broad international protection.
What tools can be used to search for related patents and prior art?
Tools like the Common Citation Document (CCD) and the Patent Public Search tool provided by the USPTO can be used to search for related patents and prior art.
How does the patent impact the market?
The grant of this patent provides the holder with a competitive edge in the veterinary pharmaceutical market, allowing exclusive marketing and sales of the formulations.
Sources
- USPTO - Search for patents: https://www.uspto.gov/patents/search
- DrugPatentWatch - Patent 11,197,847: https://www.drugpatentwatch.com/p/patent/11197847
- USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
- Yale Journal of Law & Technology - What Is the Probability of Receiving a US Patent?: https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf
- Justia Patents - Isoxazoline parasiticide formulations and methods for treating parasites: https://patents.justia.com/patent/11197847
